MAPK3 and hypertensive disorder: URB597 administrated to rats with spontaneous hypertension decreased the expression of cardiac Nrf2, HO-1, Keap1, Bach1, and KAP1; increased expression of kinases ERK1/2 and MAPK; while p21, p62, and p38 amounts were not changed.